<DOC>
	<DOCNO>NCT00416299</DOCNO>
	<brief_summary>To evaluate use new cardiac biomarker prediction in-hospital cardiovascular complication elderly patient undergo elective cardiac surgery .</brief_summary>
	<brief_title>Prognostic Value New Cardiac Biomarkers Elderly Patients Undergoing Cardiac Surgery</brief_title>
	<detailed_description>Plasma N-terminal pro-brain natriuretic peptide ( NT-proBNP , cardiac troponin T ( cTnT ) , pregnancy-associated plasma protein A ( PAPP-A ) , ischemia-modified albumin ( IMA ) , myeloperoxidase ( MPO ) , metalloproteinase ( MMP ) soluble CD 40 ligand ( sCD40L ) , inflammatory cytokine level measure 100 elderly patient undergo elective cardiac surgery cardiopulmonary bypass induction anesthesia 12 h , 24 h , 48 h surgery . Optimum discriminator prediction postoperative cardiovascular complication wil determine use receiver operate characteristic ( ROC ) curve analysis .</detailed_description>
	<criteria>patient age 75 year old undergo elective cardiac surgery CPB positive cardiac troponin T test within week surgery patient undergo emergent procedure patient preoperative mechanical cardiac support patient undergoing hemodialysis</criteria>
	<gender>All</gender>
	<minimum_age>75 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2009</verification_date>
	<keyword>Cardiac biomarker</keyword>
	<keyword>cardiac surgery</keyword>
	<keyword>elderly</keyword>
	<keyword>postoperative complication</keyword>
	<keyword>Patients age 75 year old undergoing cardiac surgery</keyword>
</DOC>